Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT›Acknowledgements

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT · Acknowledgements

Acknowledgements

CC BY 4.0 · National Institute for Health and Care Research · approximately 8 min read

We gratefully acknowledge the hard work, support and advice from the following.

Day-to-day research activities, including participant screening, recruitment, data collection, and assisting with trial set-up and monitoring

Daniel Kelleher, Vanessa Moore and Saba Alam (Humber NHS Foundation Trust); Jules Beresford-Dent, Jamie Barrow, Megan Garside, Ellen Kingsley and Eleni Tsappis (Leeds & York Partnership NHS Foundation Trust); Joseph Horne (University of York); Daniel Beever (University of Sheffield Clinical Trials Unit); Kayte Russell, Zoe Inman, Michelle Hagon-Powley, Caroline Sheldon and Lauren Wright (Norfolk and Suffolk NHS Foundation Trust); Emily Clare (Northumberland, Tyne & Wear NHS Foundation Trust); Alix Smith (Rotherham, Doncaster & South Humber NHS Foundation Trust); Laura Daniells and Hollie Gay (University of Exeter Research Clinic); Brandon Bule, Rebecca Ledden and Stephanie Willshaw (Dorset Healthcare University NHS Foundation Trust); and Aurora Balalia, Amelia Parchment and Florentina Takacs (Dudley & Walsall NHS Foundation Trust).

Support on data management concerns

Chris Turtle, Tim Chater, Munya Dimairo (statistical cover for maternity leave) and Kirsty Pemberton (University of Sheffield Clinical Trials Unit).

Administrative and clerical support

Jessica Welburn, Elizabeth Skelton, Daniel Gottschalk and Heather Dakin (University of Sheffield); and Catherine Arthurson and Sharon Bird (Leeds & York Partnership NHS Foundation Trust).

Support on ethics and governance issues

Sinead Audsley (Leeds & York Partnership NHS Foundation Trust).

Patient and public involvement

Trilby Breckman (Triumph Over Phobia, Bath, UK), Olivia Lawler and York Youth Council.

We offer special thanks to the members of our two oversight committees.

Trial Steering Committee

Professor Cathy Creswell (Professor of Developmental Clinical Psychology, University of Reading), Professor Ian Norman (Professor of Mental Health, King’s College London), Dr Claire Henderson (Reader in Public Mental Health, King’s College London), Professor Dankmar Böhning (Professor of Statistics, University of Southampton) and Olivia Lawler (PPI representative).

Data Monitoring and Ethics Committee

Professor Chris Williams (Professor of Psychosocial Psychiatry, University of Glasgow), Professor Nigel Stallard (Professor of Medical Statistics, University of Warwick) and Dr Robbie Duschinsky (Senior University Lecturer, University of Cambridge).

The ASPECT research team

Trial Management Group

Professor Barry Wright (LYPFT/University of York), Professor Cindy Cooper (University of Sheffield Clinical Trials Unit), Dr Alex Scott (University of Sheffield Clinical Trials Unit), Lucy Tindall (LYPFT), Katie Biggs (University of Sheffield Clinical Trials Unit), Dr Dawn Teare (University of Sheffield), Dr Ellen Lee (University of Sheffield), Emily Hayward (LYPFT), Hannah Edwards (LYPFT), Jen Lomas (University of Sheffield Clinical Trials Unit), Amy Barr (University of Sheffield), Kiera Solaiman (University of Sheffield), Dr David Marshall (University of York), Professor Dean McMillan (University of York), Dr Shehzad Ali (Western University Canada/University of York), Han-I Wang (University of York), Dr Lina Gega (University of York), Joseph Horne (University of York), Rebecca Hargate (LYPFT), Dr Penny Bee (University of Manchester), Professor Karina Lovell (University of Manchester), Trilby Breckman (Triumph Over Phobia UK), Jon Wilson (Norfolk and Suffolk NHS Foundation Trust), Clare Elsdon (City of York Council), Chris Turtle (University of Sheffield) and Munya Dimairo (University of Sheffield).

Co-applicants

Professor Cindy Cooper (University of Sheffield Clinical Trials Unit), Katie Biggs (University of Sheffield Clinical Trials Unit), Dr Dawn Teare (University of Sheffield), Dr David Marshall (University of York), Professor Dean McMillan (University of York), Dr Lina Gega (University of York), Dr Shehzad Ali (Western University Canada/University of York), Professor Simon Gilbody (University of York), Rebecca Hargate (LYPFT), Dr Penny Bee (University of Manchester), Professor Karina Lovell (University of Manchester), Dr Thompson Davis (Louisiana State University) and Trilby Breckman (Triumph Over Phobia UK).

Local principal investigators

Ravi Mahendra (Humber NHS Foundation Trust), Ollie O’Mara (Tees, Esk & Wear Valley Foundation Trust), Simon Eltringham (South West Yorkshire Partnership NHS Foundation Trust), Jon Wilson (Norfolk & Suffolk NHS Foundation Trust), Lina Gega (Northumberland, Tyne & Wear NHS Foundation Trust/South Tyneside and Sunderland NHS Foundation Trust), Katie Glazebrook (Leeds Community Healthcare Trust), Adrian Philipson (Rotherham, Doncaster & South Humber NHS Foundation Trust), Catherine Gallop (University of Exeter Research Clinic), Jennifer Murphy (Dorset Healthcare University NHS Foundation Trust), Deborah Vaughn (Cumbria Partnership NHS Foundation Trust), Dawn Egginton (County Durham and Darlington NHS Foundation Trust), and Arif Khan and Sita Ratner (Dudley & Walsall NHS Foundation Trust).

We would also like to extend our thanks to all of the CYP, parents/guardians and clinicians who were involved in ASPECT. Furthermore, we thank those who allowed the successful delivery of the trial through providing phobic stimuli for assessments and therapy sessions.

The views expressed in this report are those of the authors and not necessarily those of the National Institute for Health and Care Research Health Technology Assessment programme. Any errors are the responsibility of the authors.

Contributions of authors

Barry Wright (https://orcid.org/0000-0002-8692-6001) (Co-applicant/Chief Investigator) was involved in trial conception and design, delivered study intervention training, was involved in the analysis and interpretation of the data, contributed to the management and conduct of the trial, and produced the first draft of the report.

Lucy Tindall (https://orcid.org/0000-0002-7486-5037) (Trial Manager) contributed to the management and conduct of the trial and produced the first draft of the report.

Alexander J Scott (https://orcid.org/0000-0001-7426-7099) (Trial Manager) contributed to the management and conduct of the trial and produced the first draft of the report.

Ellen Lee (https://orcid.org/0000-0003-4529-7410) (Statistician) was involved in the analysis and interpretation of the data and produced the first draft of the report.

Katie Biggs (https://orcid.org/0000-0003-4468-7417) (Co-applicant/Assistant Director of CTRU) was involved in trial conception and design, was involved in the analysis and interpretation of the data, contributed to the management and conduct of the trial, and produced the first draft of the report.

Cindy Cooper (https://orcid.org/0000-0002-2995-5447) (Co-applicant/Director of CTRU) was involved in trial conception and design, was involved in the analysis and interpretation of the data, contributed to the management and conduct of the trial, and produced the first draft of the report.

Penny Bee (https://orcid.org/0000-0002-5600-0400) (Co-applicant) was involved in trial conception and design, was involved in the analysis and interpretation of the data, and produced the first draft of the report.

Han-I Wang (https://orcid.org/0000-0002-3521-993X) (Health Economist) was involved in the analysis and interpretation of the data, and produced the first draft of the report.

Lina Gega (https://orcid.org/0000-0003-2902-9256) (Co-applicant/Principal Investigator) was involved in trial conception and design, delivered study intervention training, and was involved in the analysis and interpretation of the data.

Emily Hayward (https://orcid.org/0000-0002-2413-0104) (Research Assistant) was involved in the acquisition, analysis and interpretation of the data, and produced the first draft of the report.

Kiera Solaiman (https://orcid.org/0000-0003-2244-5345) (Research Assistant) was involved in the acquisition, analysis and interpretation of the data, and produced the first draft of the report.

M Dawn Teare (https://orcid.org/0000-0003-3994-0051) (Co-applicant/Senior Statistician) was involved in trial conception and design, and was involved in the analysis and interpretation of the data.

Thompson Davis (https://orcid.org/0000-0002-5180-8822) (Co-applicant) was involved in trial conception and design, delivered study intervention training, and was involved in the analysis and interpretation of the data.

Karina Lovell (https://orcid.org/0000-0001-8821-895X) (Co-applicant) was involved in trial conception and design, and was involved in the analysis and interpretation of the data.

Jon Wilson (https://orcid.org/0000-0002-5279-6237) (Co-applicant/Principal Investigator) was involved in trial conception and design, and was involved in the analysis and interpretation of the data.

Dean McMillan (https://orcid.org/0000-0002-2901-8410) (Co-applicant) was involved in trial conception and design, and was involved in the analysis and interpretation of the data.

Amy Barr (https://orcid.org/0000-0002-7990-7451) (Research Assistant) was involved in the acquisition, analysis and interpretation of the data.

Hannah Edwards (https://orcid.org/0000-0002-0500-2123) (Research Assistant) was involved in the acquisition, analysis and interpretation of the data.

Jennifer Lomas (https://orcid.org/0000-0002-2446-7153) (Research Assistant) was involved in the acquisition, analysis and interpretation of the data.

Chris Turtle (https://orcid.org/0000-0003-3109-425X) (Data Specialist) was involved in the analysis and interpretation of the data, and contributed to the management and conduct of the trial.

Steve Parrott (https://orcid.org/0000-0002-0165-1150) (Senior Health Economist) was involved in the analysis and interpretation of data.

Catarina Teige (https://orcid.org/0000-0002-8958-6487) (Trial Manager) contributed to the management and conduct of the trial.

Tim Chater (https://orcid.org/0000-0002-1138-0147) (Data and Information Systems Manager) was involved in the analysis and interpretation of the data, and contributed to the management and conduct of the trial.

Rebecca Hargate (https://orcid.org/0000-0001-6532-2375) (Co-applicant) was involved in trial conception and design.

Shehzad Ali (https://orcid.org/0000-0002-8042-3630) (Co-applicant) was involved in trial conception and design.

Sarah Parkinson (https://orcid.org/0000-0003-3512-8509) (Research Assistant) was involved in the acquisition of data.

Simon Gilbody (https://orcid.org/0000-0002-8236-6983) (Co-applicant) was involved in trial conception and design.

David Marshall (https://orcid.org/0000-0001-5969-9539) (Co-applicant) was involved in trial conception and design.

All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Publications

Hayward E, Solaiman K, Bee P, Barr A, Edwards H, Lomas J, et al. One-session treatment for specific phobias: barriers, facilitators and acceptability as perceived by children & young people, parents, and clinicians. PLOS ONE 2022;17:e0274424.

Tindall L, Scott AJ, Biggs K, Hayward E, Wilson J, Cooper C, et al. The Alleviating Specific Phobias in Children Trial: challenges and solutions to implementing a randomised controlled trial in clinical services. Front Child Adolesc Psychiatry 2022; in press.

Wang HI, Wright B, Tindall L, Cooper C, Biggs K, Lee E, et al. Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT): results from a randomised controlled trial. BMJ Psychiatry 2022;22:547.

Wright B, Tindall L, Scott AJ, Lee E, Cooper C, Bee P, et al. One session treatment (OST) is equivalent to multi-session cognitive behavioural therapy (CBT) in children with specific phobias (ASPECT): results from a national non-inferiority randomized controlled trial [published online ahead of print August 1 2022]. J Child Psychol Psychiatry 2022.

Data-sharing statement

Any requests for statistical code should be made to the corresponding author or the CTRU. The ASPECT management team will consider the sharing of data on a case-by-case basis in line with the ethics approval and patient information sheets. Any presented data do not contain any direct identifiers.

Disclaimers

This report presents independent research funded by the National Institute for Health and Care Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, the HTA programme or the Department of Health and Social Care. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, the HTA programme or the Department of Health and Social Care.

← ReferencesList of supplementary material →

Attribution. Barry Wright; Lucy Tindall; Alexander J Scott; Ellen Lee; Katie Biggs; Cindy Cooper et al. (2022). One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT. National Institute for Health and Care Research. Copyright © 2022 Wright et al. This work was produced by Wright et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: http://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited. Licensed under CC BY 4.0. NCBI Bookshelf NBK585874. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • Acknowledgements

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support